110 related articles for article (PubMed ID: 3535832)
1. The hybridoma technology: II. Applications of hybrid cell products: monoclonal antibodies and lymphokines.
Epstein N; Kobiler D; Epstein M
Adv Biotechnol Processes; 1986; 6():219-51. PubMed ID: 3535832
[No Abstract] [Full Text] [Related]
2. Immunochemical techniques. Part I: Hybridoma technology and monoclonal antibodies.
Methods Enzymol; 1986; 121():1-947. PubMed ID: 3523121
[No Abstract] [Full Text] [Related]
3. Expression of cell surface antigens by suppressor T cell hybridomas. I. Comparison of phenotype and function.
Trial J; Kapp JA; Pierce CW; Shreffler DC; Sorensen CM; Waltenbaugh C
J Immunol; 1983 Feb; 130(2):565-72. PubMed ID: 6217244
[TBL] [Abstract][Full Text] [Related]
4. The hybridoma technology: I. Production of monoclonal antibodies.
Epstein N; Epstein M
Adv Biotechnol Processes; 1986; 6():179-218. PubMed ID: 3535831
[No Abstract] [Full Text] [Related]
5. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
Salgar SK; Paape MJ; Alston-Mills B
Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies: convergence of technology and application.
Raff HV
Prog Clin Biol Res; 1986; 211():247-63. PubMed ID: 3008195
[No Abstract] [Full Text] [Related]
7. Analysis of lymphocyte differentiation antigens with hybridoma monoclonal antibodies.
Shiku H; Yamaguchi H; Furukawa K; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1395-400. PubMed ID: 7342646
[No Abstract] [Full Text] [Related]
8. [Monoclonal antibodies and their potential application to medicine].
Weber S
Z Erkr Atmungsorgane; 1985; 165(1):3-12. PubMed ID: 2414929
[TBL] [Abstract][Full Text] [Related]
9. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
White J; Haskins KM; Marrack P; Kappler J
J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal antibodies in pharmacology].
Uteshev BS
Farmakol Toksikol; 1986; 49(2):5-10. PubMed ID: 3011494
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies: technology and potential use.
Antczak DF
J Am Vet Med Assoc; 1982 Nov; 181(10):1005-10. PubMed ID: 6757209
[TBL] [Abstract][Full Text] [Related]
12. Changes in Lymphocyte cell surface markers in human disease states.
Williams RC
Clin Immunol Rev; 1981-1982; 1(3):409-69. PubMed ID: 6762279
[No Abstract] [Full Text] [Related]
13. Establishment of hybridoma cell lines secreting anti-Legionella pneumophila serogroup 1 monoclonal antibodies with immunodiagnostic potential.
Sethi KK; Brandis H
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):294-8. PubMed ID: 6649980
[TBL] [Abstract][Full Text] [Related]
14. [Hybridoma-produced monoclonal antibodies: the most revolutionary technique in immunobiology (author's transl)].
Ruiz-Argüelles A
Rev Invest Clin; 1982; 34(1):79-84. PubMed ID: 7046001
[No Abstract] [Full Text] [Related]
15. [Toxoplasma gondii: the characterization of an anti-P30 monoclonal antibody].
Fachado A; Fernández N; Hernández E; Fonseca L
Rev Cubana Med Trop; 1996; 48(3):178-83. PubMed ID: 9805047
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies.
Grzych JM; Capron M; Bazin H; Capron A
J Immunol; 1982 Dec; 129(6):2739-43. PubMed ID: 7142705
[TBL] [Abstract][Full Text] [Related]
17. Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens.
Kurlander RJ
J Immunol; 1983 Jul; 131(1):140-7. PubMed ID: 6223069
[TBL] [Abstract][Full Text] [Related]
18. Obtention of rat monoclonal antibodies reactive with human leukaemic lymphoblasts.
Lebacq AM; Bazin H
Bull Cancer; 1983; 70(2):93-5. PubMed ID: 6575843
[TBL] [Abstract][Full Text] [Related]
19. A serum independent medium effective in all aspects of hybridoma technology and immunological applications.
Baker P; Knoblock K; Noll L; Wyatt D; Lydersen B
Dev Biol Stand; 1985; 60():63-72. PubMed ID: 3876250
[TBL] [Abstract][Full Text] [Related]
20. A killer cell protective antigen expressed by MHC-unrestricted killer hybridomas.
Kubota K
Cell Immunol; 1997 Oct; 181(1):50-8. PubMed ID: 9344496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
